在中介开发直角选择性mAb下游工艺,以去除与工艺相关的杂质
Dongyoun Jang1, Mario A Gutierrez-Diaz1, Scott H Altern1
1Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
Biotechnology progress
|December 16, 2025
概括
这项研究提出了一个in silico工作流程,用于开发快速的非蛋白质A净化过程,以从单克隆抗体 (mAb) 治疗中去除宿主细胞蛋白 (HCP),显著减少净化步骤并提高效率.
科学领域:
- 生物技术是生物技术.
- 生物制药制造业 生物制药制造业
- 过程开发 过程开发
背景情况:
- 复合中国大鼠卵巢 (CHO) 表达系统的进步增加了治疗性单克隆抗体 (mAb) 的产生.
- 更高的生产率导致下游净化过程中宿主细胞蛋白 (HCP) 的负担更大.
- 有效的医疗人员移除对于mAb的治疗安全性和有效性至关重要.
研究的目的:
- 开发一个快速的,在中介的工作流程,用于设计三步,非蛋白质A净化过程.
- 从CHO衍生的mAb疗法中有效地去除宿主细胞蛋白 (HCP).
- 为了简化下游净化开发.
主要方法:
- 在选定的树脂,膜吸附剂和新型吸附剂上利用线性梯度屏幕来产生零混因子 (CCF) 和纯 mAb 保留模式.
- 采用RPLC (逆相液态色谱) "HCP指纹"用于HCP对关键分数的表征.
- 开发了一个in silico工具来处理保留数据并根据设计约束生成潜在的三步净化序列.
主要成果:
- 成功设计和完善了几种三步净化工艺,在板尺度上.
- 通过使用绑定-射捕获,然后通过绑定-射和流通步骤实现了91.4 ppm HCP,累计产品产量为78.7%.
- 通过使用两个无盐流通步骤,达到96.1ppm的HCP,累计产量为81.4%.
结论:
- 在 silico 工作流程有助于快速开发有效的非蛋白质A 净化策略mAbs.
- 开发的流程证明了高效的HCP移除,同时保持了高产品产量.
- 这种方法为HCP清除提供了传统蛋白质A染色体的可行替代方案.
更多相关视频
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.6K
10:50Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
15.2K
相关概念视频
Immunoprecipitation
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
